A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis

NCT05067335 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

327

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Romosozumab
DRUG: Placebo

Sponsor

UCB Biopharma SRL